ECONOMIC OUTCOMES OF BIORESORBABLE VASCULAR SCAFFOLDS VERSUS EVEROLIMUS-ELUTING STENTS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY REVASCULARIZATION: ONE YEAR RESULTS FROM THE ABSORB III TRIAL

被引：2
|
作者：
Baron, Suzanne [1 ]
Lei, Yang [1 ]
Vilain, Katherine [1 ]
Magnuson, Elizabeth [1 ]
Kereiakes, Dean [1 ]
Ellis, Stephen [1 ]
Stone, Gregg [1 ]
Cohen, David [1 ]
机构：
[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 67卷 / 13期
关键词：
D O I：
10.1016/S0735-1097(16)30020-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1207M-09
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention 1-Year Results From the ABSORB III Trial
    Baron, Suzanne J.
    Lei, Yang
    Chinnakondepalli, Khaja
    Vilain, Katherine
    Magnuson, Elizabeth A.
    Kereiakes, Dean J.
    Ellis, Stephen G.
    Stone, Gregg W.
    Cohen, David J.
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (08) : 774 - 782
  • [2] 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds The ABSORB III Trial
    Kereiakes, Dean J.
    Ellis, Stephen G.
    Metzger, Christopher
    Caputo, Ronald P.
    Rizik, David G.
    Teirstein, Paul S.
    Litt, Marc R.
    Kini, Annapoorna
    Kabour, Ameer
    Marx, Steven O.
    Popma, Jeffrey J.
    McGreevy, Robert
    Zhang, Zhen
    Simonton, Charles
    Stone, Gregg W.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (23) : 2852 - 2862
  • [3] 5-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial
    Gao, Run-Lin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B47 - B47
  • [4] Four-Year Clinical Outcomes From Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds Versus Everolimus-eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial
    Gao, Runlin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B128 - B128
  • [5] Bioresorbable vascular scaffolds versus everolimus-eluting stents: a biomechanical analysis of the ABSORB III Imaging substudy
    Kumar, Arnav
    Gogas, Bill D.
    Thompson, Elizabeth W.
    Burnett, Grady Murphy
    Molony, David
    Hosseini, Hossein
    Chandran, Karthic
    Lefieux, Adrien
    Honda, Yasuhiro
    Lee, Joo Myung
    Serruys, Patrick W.
    Kereiakes, Dean J.
    Stone, Gregg W.
    Samady, Habib
    [J]. EUROINTERVENTION, 2020, 16 (12) : E989 - +
  • [6] Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
    Onuma, Yoshinobu
    Chevalier, Bernard
    Ono, Masafumi
    Cequier, Angel
    Dudek, Dariusz
    Haude, Michael
    Carrie, Didier
    Sabate, Manel
    Windecker, Stephan
    Rapoza, Richard
    West, Nick E. J.
    Reith, Sebastian
    Almeida, Manuel de Sousa
    Campo, Gianluca
    Iniguez, Andres
    Serruys, Patrick W.
    [J]. EUROINTERVENTION, 2020, 16 (11) : E938 - E941
  • [7] A randomized trial evaluating everolimus-eluting Absorb bioresorbable scaffolds vs. everolimus-eluting metallic stents in patients with coronary artery disease: ABSORB Japan
    Kimura, Takeshi
    Kozuma, Ken
    Tanabe, Kengo
    Nakamura, Sunao
    Yamane, Masahisa
    Muramatsu, Toshiya
    Saito, Shigeru
    Yajima, Junji
    Hagiwara, Nobuhisa
    Mitsudo, Kazuaki
    Popma, Jeffrey J.
    Serruys, Patrick W.
    Onuma, Yoshinobu
    Ying, Shihwa
    Cao, Sherry
    Staehr, Peter
    Cheong, Wai-Fung
    Kusano, Hajime
    Stone, Gregg W.
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (47) : 3332 - 3342
  • [8] Three-year clinical outcomes of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Final results of the ABSORB EXTEND trial
    Ribamar Costa, J., Jr.
    Abizaid, Alexandre
    Whitbourn, Robert
    Serruys, Patrick W.
    Jepson, Nigel
    Steinwender, Clemens
    Stuteville, Marrianne
    Ediebah, Divine
    Sudhir, Krishnankutty
    Bartorelli, Antonio L.
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2019, 93 (01) : E1 - E7
  • [9] Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial
    Xu, Bo
    Yang, Yuejin
    Han, Yaling
    Huo, Yong
    Wang, Lefeng
    Qi, Xiangqian
    Li, Jifu
    Chen, Yundai
    Kuo, Hai-Chien
    Ying, Shih-Wa
    Cheong, Wai-Fung
    Zhang, Yunlong
    Su, Xiaolu
    Popma, Jeffery J.
    Gao, Runlin
    Stone, Gregg W.
    [J]. EUROINTERVENTION, 2018, 14 (05) : 554 - 561
  • [10] Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial
    Wiebe, Jens
    Byrne, Robert A.
    Alfonso, Fernando
    Maeng, Michael
    Bradaric, Christian
    Kretov, Evgeny
    Cuesta, Javier
    Kuna, Constantin
    Ibrahim, Tareq
    Rivero, Fernando
    Heugl, Mira
    Christiansen, Evald H.
    Joner, Michael
    Schunkert, Heribert
    Laugwitz, Karl-Ludwig
    Kastrati, Adnan
    Cassese, Salvatore
    [J]. EUROINTERVENTION, 2022, 17 (16) : 1348 - +
12345